Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-13-026011
Filing Date
2013-08-26
Accepted
2013-08-26 17:18:01
Documents
1
Period of Report
2013-07-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 11111
  Complete submission text file 0001127602-13-026011.txt   12439
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1929 BRASSFIELD ROAD RALEIGH NC 27614
Business Address
Barnes Alane P (Reporting) CIK: 0001584348 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23186 | Film No.: 131060876